Word

SANGENTRI

Status

Pending

Status Code

733

Status Date

Friday, October 27, 2023

Serial Number

90382648

Mark Type

4000

Filing Date

Tuesday, December 15, 2020

Published for Opposition

Tuesday, July 13, 2021

Trademark Owner History

Sarepta Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases

Trademark Events

Oct 31, 2023

Notice Of Approval Of Extension Request E-Mailed

Oct 27, 2023

Sou Extension 4 Granted

Oct 27, 2023

Sou Extension 4 Filed

Oct 27, 2023

Sou Teas Extension Received

Apr 20, 2023

Notice Of Approval Of Extension Request E-Mailed

Apr 18, 2023

Sou Extension 3 Granted

Apr 18, 2023

Sou Extension 3 Filed

Apr 18, 2023

Sou Teas Extension Received

Nov 3, 2022

Notice Of Approval Of Extension Request E-Mailed

Nov 1, 2022

Sou Extension 2 Granted

Nov 1, 2022

Sou Extension 2 Filed

Nov 1, 2022

Sou Teas Extension Received

Apr 29, 2022

Notice Of Approval Of Extension Request E-Mailed

Apr 27, 2022

Sou Extension 1 Granted

Apr 27, 2022

Sou Extension 1 Filed

Apr 27, 2022

Sou Teas Extension Received

Nov 2, 2021

Noa E-Mailed - Sou Required From Applicant

Sep 22, 2021

Extension Of Time To Oppose Process - Terminated

Aug 11, 2021

Extension Of Time To Oppose Received

Jul 13, 2021

Official Gazette Publication Confirmation E-Mailed

Jul 13, 2021

Published For Opposition

Jun 23, 2021

Notification Of Notice Of Publication E-Mailed

Jun 4, 2021

Approved For Pub - Principal Register

Jun 3, 2021

Teas/Email Correspondence Entered

Jun 3, 2021

Correspondence Received In Law Office

Jun 3, 2021

Teas Response To Office Action Received

May 31, 2021

Notification Of Non-Final Action E-Mailed

May 31, 2021

Non-Final Action E-Mailed

May 31, 2021

Non-Final Action Written

May 29, 2021

Assigned To Examiner

Feb 23, 2021

New Application Office Supplied Data Entered

Dec 18, 2020

New Application Entered